<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-06-03T15:52:43Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/C973CC6F-B6B7-445A-92ED-1FF8A9DC302F" ns1:id="C973CC6F-B6B7-445A-92ED-1FF8A9DC302F"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/ED9E162A-F482-45F9-9224-B8D36110380D" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/362276FA-9E5A-44ED-B712-530B69176157" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/16825DC3-D7E5-4726-B60E-2FDB985F2911" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/362276FA-9E5A-44ED-B712-530B69176157" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2016-03-30T23:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/AC038E96-12F6-4125-8BBE-7AB7A831B607" ns1:rel="FUND" ns1:start="2015-03-31T23:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">131836</ns2:identifier></ns2:identifiers><ns2:title>PeriTune - a clonal optimisation platform</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Feasibility Studies</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>A variety of micro-organisms including E. coli and S. cerevisiae (baker's yeast), are used in commercial bio-production processes to manufacture a number of products, ranging from high-value low-volume products, such bio-therapeutics (e.g. recombinant insulin), to mid-value products, (e.g. biocatalysts and specialised chemicals), to low-value bulk commodity products (e.g. succinic acid and biofuels). This project will seek to develop a robust clone optimsiation platform for the potential use and application in the above industrial sectors, and so would be of great benefit in a number of applied and fundamental areas of biological and biomedical R&amp;amp;D.</ns2:abstractText></ns2:project>